Becton Dickinson & Co.: Device Recall
Recall #Z-2023-2024 · 05/07/2024
Class II: Risk
Recall Details
- Recall Number
- Z-2023-2024
- Classification
- Class II
- Product Type
- Device
- Recalling Firm
- Becton Dickinson & Co.
- Status
- Ongoing
- Date Initiated
- 05/07/2024
- Location
- Sparks, MD, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,061 kits
Reason for Recall
Assays may produce false negative results due to decreased activity of the enzyme utilized in manufacturing.
Product Description
BD SARS-CoV-2 Reagents for BD MAX" Systems. RT-PCR test to detect SARS-CoV-2 in nasal, nasopharyngeal, oropharyngeal swab specimens, and saliva specimens.
Distribution Pattern
Domestic: Nationwide Distribution; Foreign: AU, BR, BE, CA, CO, & JP.
Other Recalls by Becton Dickinson & Co.
- Class II: Risk 10/23/2025
- Class II: Risk 09/23/2025
- Class II: Risk 09/23/2025
- Class II: Risk 09/23/2025
- Class II: Risk 09/23/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.